OXON EPIDEMIOLOGY AT ISPE ANNUAL MEETING
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
OXON will be supporting the International Conference on Pharmacoepidemiology and Therapeutic Risk Management (ICPE) in Philadelphia on August 24-28, 2019.
Understanding Health Care in Germany is our upcoming webinar. Registration is open for professionals in Pharma companies willing to learn about how to conduct observational studies in this scenario.
The Nordics is within OXON’s 2019/20 webinar series to help understand health care for conducting optimal observational studies.
22nd – 23rd May 2019,
Holiday Inn London Kensington Hotel, London UK
Nawab Qizilbash, Head of OXON, will be speaking about PASS Studies.
The third of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
The second of OXON’s webinar series from leading national pharmaco-epidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
A webinar series from leading national pharmacoepidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
A webinar series from leading national pharmacoepidemiologists spread over many months to provide a phased educational experience to learn about health care for conducting optimal observational studies.
Visit our booth B36 at DIA. If you are interested in an optimal safety (PASS) study, OXON’s expert team, supported by consultancy from Stuart Pocock, Professor of Medical Statistics, London School of Hygiene and Tropical Medicine can help you face your PASS and PAES challenges.
OXON will be exhibiting and presenting at ISPOR in Barcelona. OXON’s focus during the event will be HEOR within observational studies.